ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CNTX Context Therapeutics Inc

1.93
-0.04 (-2.03%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 135,247
Bid Price 0.47
Ask Price 3.00
News (2)
Day High 2.01

Low
0.77

52 Week Range

High
2.24

Day Low 1.8655
Share Name Share Symbol Market Stock Type
Context Therapeutics Inc CNTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -2.03% 1.93 23:00:02
Open Price Low Price High Price Close Price Previous Close
1.97 1.8655 2.01 1.96 1.97
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,098 135,247 US$ 1.96 US$ 264,749 - 0.77 - 2.24
Last Trade Type Quantity Price Currency
18:27:14 formt 223 US$ 1.93 USD

Context Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
31.29M 15.97M - 0 -23.96M -1.50 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Context Therapeutics News

Date Time Source News Article
6/14/202406:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/14/202406:34Edgar (US Regulatory)Form 8-K - Current report
6/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
5/31/202415:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
5/24/202415:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
5/24/202406:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
5/10/202415:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
5/08/202415:06GlobeNewswire Inc.Context Therapeutics Reports First Quarter 2024 Operating..
5/08/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/02/202406:31GlobeNewswire Inc.Context Therapeutics Announces FDA Clearance of IND..
5/02/202406:30GlobeNewswire Inc.Context Therapeutics Announces $100 Million Private..
4/01/202406:30GlobeNewswire Inc.Context Therapeutics Submits IND Application to Evaluate..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CNTX Message Board. Create One! See More Posts on CNTX Message Board See More Message Board Posts

Historical CNTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.742.241.641.98263,3880.1910.92%
1 Month1.842.241.3521.96207,6350.094.89%
3 Months1.092.241.081.76640,6000.8477.06%
6 Months0.952.240.8351.70325,6870.98103.16%
1 Year1.242.240.771.65181,7910.6955.65%
3 Years4.4410.870.473.81833,590-2.51-56.53%
5 Years4.4410.870.473.81833,590-2.51-56.53%

Context Therapeutics Description

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Your Recent History

Delayed Upgrade Clock